SYNGENE INTERNATIONAL LIMITED Company Profile Details at KooCapital.Com – Stock Market News Portal.
Syngene International Limited operates as a global discovery, development and manufacturing organization providing integrated scientific services to the pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical industries. It is engaged providing contract research and manufacturing services. The firm’s services include discovery chemistry, discovery biology, safety assessment, large molecule development, chemical development, formulation development, stability studies, polymer research, integrated discovery and development, and clinical development. The company was founded on November 18, 1993 and is headquartered in Bangalore, India.
syngene international limited company operating in Health Technology Sector and dealing in Biotechnology. syngene international limited is SEBI Listed Company (India) and having:-
ISIN (An International Securities Identification Number): INE398R01022
Equity Stock (National Stock Exchange) Symbol: SYNGENE
NSE Link IS: https://www.nseindia.com/get-quotes/equity?symbol=SYNGENE
BSE Link IS: https://www.bseindia.com/stock-share-price/syngene-international-ltd/SYNGENE/539268/
Syngene (established in 1993) as a Biocon subsidiary is India’s first Contract Research Organization (CRO) which expanded later to be an integrated service provider offering end-to-end drug discovery, development, and manufacturing services on a single platform (CRAMS). Total research & manufacturing infrastructure for the company is spread across 1.9 million square feet across locations.
Business Footprint: The company caters to diverse end-user industries like Pharmaceuticals, Animal Health, Agrochemicals, Consumer Packaged Goods, Chemicals/Polymers. It has 360+ active customers with engagements with 8 out of the top 10 global pharma companies. The company holds 400+ patents jointly with clients and has a base of 4200+ scientists.
Syngene International Ltd. (BSE: 539268, NSE: SYNGENE, ISIN: INE398R01022) is an integrated contract research, development and manufacturing organization providing scientific services – from early discovery to commercial supply. Our innovative capabilities for novel molecular entities (NMEs) cater to a wide range of industrial sectors, including pharmaceutical, biotechnology, nutrition, animal health, consumer goods and speciality chemical companies.
Our Discovery services include conducting early-stage research from target identification to delivery of drug candidates for further development. Development services encompass activities from pre-clinical to clinical trials including Drug Substance Development (DSP), Drug Product Development (DPD) and associated services to demonstrate safety, tolerability and efficacy of the selected drug candidate.
Our Manufacturing services for small and large molecules include cGMP-compliant facilities for clinical supplies, registration batches as well as commercial volumes through our API manufacturing plant & disposable Biologics manufacturing facility.
Driving our innovative culture is our highly qualified team of 4700+ scientists supported by state-of-the-art infrastructure and market-leading technology. Our scientists have both the skills and the capability to deliver great science, ensure robust data management, IP security & quality manufacturing, at speed, to improve time-to-market and lower the cost of innovation.
With 2 Mn sq ft of specialist discovery, development & manufacturing facilities, Syngene offers dedicated research facilities for Amgen, Baxter, Bristol-Myers Squibb and Herbalife. We also work with biotech companies pursuing leading-edge science as well as multinationals including GSK and Merck KGaA. Smaller and virtual companies, non-profit institutions, academic centers and start-ups also collaborate with us for their research-related requirements.
Write to us at bdc@syngeneintl.com
Syngene International Limited stand with [An innovation-led, contract research, development & manufacturing organization offering integrated scientific services]
Company Website: https://www.syngeneintl.com/
Company Website2: http://www.syngeneintl.com/
LinkedIn page URL: https://in.linkedin.com/company/syngene-international-limited
Wiki Profile URL:
Popular Search Keywords: syngene international limited , company management , company history , company profile , company information , business directory , Stock Market News , annual report , quarterly results , profit and loss , Koo Capital , KooCapital.Com , KooCapital News , Health Technology Sector Company , Biotechnology industry
#syngene #international #limited #company #management #company #history #company #profile #company #information #business #directory #stock #market #news #annual #report #quarterly #results #profit #and #loss #koo #capital #koocapital #com #koocapital #news #health #technology #sector #company #biotechnology #industry
